Felbamate is a subunit selective modulator of recombinant γ-aminobutyric acid type A receptors expressed in Xenopus oocytes

Timothy Simeone, James F. Otto, Karen S. Wilcox, H. Steve White

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Felbamate (2-phenyl-1,3-propanediol dicarbamate) is clinically available for the treatment of refractory epileptic seizures, and is known to modulate several ion channels including γ-aminobutyric acid type A (GABAA) receptors. To determine felbamate subunit selectivity for GABAA receptors we expressed 15 different GABAA receptor combinations in Xenopus laevis oocytes. Felbamate positively modulated GABA-currents of α1β2γ2S, α1β3γ2S, α2β2γ2S and α2β3γ2S, whereas felbamate was either ineffective or negatively modulated the other 11 receptor combinations. Regional distributions of GABAA receptor subunits suggest that felbamate may differentially modulate distinct inhibitory circuits, a possibility that may have relevance to felbamate efficacy in refractory epilepsies.

Original languageEnglish
Pages (from-to)31-35
Number of pages5
JournalEuropean Journal of Pharmacology
Volume552
Issue number1-3
DOIs
StatePublished - Dec 15 2006

Fingerprint

felbamate
Aminobutyrates
Xenopus
Oocytes
GABA-A Receptors
Epilepsy
Xenopus laevis
Ion Channels
gamma-Aminobutyric Acid

All Science Journal Classification (ASJC) codes

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Felbamate is a subunit selective modulator of recombinant γ-aminobutyric acid type A receptors expressed in Xenopus oocytes. / Simeone, Timothy; Otto, James F.; Wilcox, Karen S.; White, H. Steve.

In: European Journal of Pharmacology, Vol. 552, No. 1-3, 15.12.2006, p. 31-35.

Research output: Contribution to journalArticle

@article{e96811786b744704b6633f90092e87b2,
title = "Felbamate is a subunit selective modulator of recombinant γ-aminobutyric acid type A receptors expressed in Xenopus oocytes",
abstract = "Felbamate (2-phenyl-1,3-propanediol dicarbamate) is clinically available for the treatment of refractory epileptic seizures, and is known to modulate several ion channels including γ-aminobutyric acid type A (GABAA) receptors. To determine felbamate subunit selectivity for GABAA receptors we expressed 15 different GABAA receptor combinations in Xenopus laevis oocytes. Felbamate positively modulated GABA-currents of α1β2γ2S, α1β3γ2S, α2β2γ2S and α2β3γ2S, whereas felbamate was either ineffective or negatively modulated the other 11 receptor combinations. Regional distributions of GABAA receptor subunits suggest that felbamate may differentially modulate distinct inhibitory circuits, a possibility that may have relevance to felbamate efficacy in refractory epilepsies.",
author = "Timothy Simeone and Otto, {James F.} and Wilcox, {Karen S.} and White, {H. Steve}",
year = "2006",
month = "12",
day = "15",
doi = "10.1016/j.ejphar.2006.09.002",
language = "English",
volume = "552",
pages = "31--35",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1-3",

}

TY - JOUR

T1 - Felbamate is a subunit selective modulator of recombinant γ-aminobutyric acid type A receptors expressed in Xenopus oocytes

AU - Simeone, Timothy

AU - Otto, James F.

AU - Wilcox, Karen S.

AU - White, H. Steve

PY - 2006/12/15

Y1 - 2006/12/15

N2 - Felbamate (2-phenyl-1,3-propanediol dicarbamate) is clinically available for the treatment of refractory epileptic seizures, and is known to modulate several ion channels including γ-aminobutyric acid type A (GABAA) receptors. To determine felbamate subunit selectivity for GABAA receptors we expressed 15 different GABAA receptor combinations in Xenopus laevis oocytes. Felbamate positively modulated GABA-currents of α1β2γ2S, α1β3γ2S, α2β2γ2S and α2β3γ2S, whereas felbamate was either ineffective or negatively modulated the other 11 receptor combinations. Regional distributions of GABAA receptor subunits suggest that felbamate may differentially modulate distinct inhibitory circuits, a possibility that may have relevance to felbamate efficacy in refractory epilepsies.

AB - Felbamate (2-phenyl-1,3-propanediol dicarbamate) is clinically available for the treatment of refractory epileptic seizures, and is known to modulate several ion channels including γ-aminobutyric acid type A (GABAA) receptors. To determine felbamate subunit selectivity for GABAA receptors we expressed 15 different GABAA receptor combinations in Xenopus laevis oocytes. Felbamate positively modulated GABA-currents of α1β2γ2S, α1β3γ2S, α2β2γ2S and α2β3γ2S, whereas felbamate was either ineffective or negatively modulated the other 11 receptor combinations. Regional distributions of GABAA receptor subunits suggest that felbamate may differentially modulate distinct inhibitory circuits, a possibility that may have relevance to felbamate efficacy in refractory epilepsies.

UR - http://www.scopus.com/inward/record.url?scp=33750466915&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750466915&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2006.09.002

DO - 10.1016/j.ejphar.2006.09.002

M3 - Article

VL - 552

SP - 31

EP - 35

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1-3

ER -